Cite

HARVARD Citation

    Chan, P. et al. (2017). A major responder to ipilimumab and nivolumab in metastatic uveal melanoma with concomitant autoimmunity. Pigment cell & melanoma research. pp. 558-562. [Online]. 
  
Back to record